Monthly Archives: July 2024

MP Group: Outlook on Global Medical Communications Outsourcing

Pleasure to share with you our Outlook on ‘Global Medical Communications Outsourcing’. Medical communications is becoming an integral part of drug development and commercialization strategy, owing to the pursuit of innovative and complex therapies, articulation of medical and economic benefits and adopting a patient-centric approach. As a result, the medical communications outsourcing market, from a current base of ~$2B in 2023, is expected to reach ~$8B by 2026, growing at a CAGR of 18%. The evolution of technology and omnichannel…

Continue Reading

MP Group: Outlook on Growth of the US biosimilars market – Key trends and opportunities

Pleasure to share our Outlook on Growth of the US biosimilars market – Key trends and opportunities. Historically, the US biosimilars market has posed several challenges restricting its penetration. Ambiguous regulatory guidelines contributing to high cost and timelines for development, patent dance causing uncertainties with launch timelines and barriers posed by the innovators limiting the market penetration – all of these led to the biosimilars market only dominated by the innovator companies. However, over the last 3-5 years, the landscape…

Continue Reading
Close Menu